Report from the European Society of Cardiology Congress 2015 in London
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2015, Vol 2, Issue 4
Abstract
At least for us, the ESC Congress 2015 in London was different from the previous ones as we did not organize Satellite Symposium on rare cardiovascular diseases. It is not that we did not want to, on the contrary we tried as much as we could, but due to the fact that our EU Project MRPO 08.02.00‐12-424/10 has eventually came to an end we did not possess adequate financial back‐up to organize the session. Certainly, this is not good news for all somehow accustomed to our annual session, but on the other hand the light we torched some time ago has not been extinguished. During numerous informal meetings at the Congress we tried to cultivate what we had jointly started some time ago. As in real life, there are ups and downs and it is not difficult to carry on when everything clicks into place but real challenge is to survive even in the dark days. But now a little about the Congress itself.
Authors and Affiliations
Pawel Rubis
Keywords
Related Articles
- EP ID EP242024
- DOI 10.20418/jrcd.vol2no4.203
- Views 110
- Downloads 0
The 51‐year‐old patient with a non‐compaction cardiomiopathy and multi‐vessel coronary artery disease (RCD code: III-5A.1)
Left ventricular non-compaction (LVNC) or "spongy myocardium", is a rare form of a primary genetic cardiomyopathy considered to be the result of abnormal intrauterine arrest of the myocardial compaction process [1]. Left...
Partial anomalous pulmonary venous connection (RCD code: II-3C.0)
A 48-year-old woman was admitted to our institution with a year’s history of uncharacteristic chest pain episodes and decrease in exercise tolerance. A CT lung scan performed nine months earlier revealed an anomalous vei...
World Rare Disease Day – 29th of February 2016 III Conference of Rare Cardiovascular Diseases at John Paul II Hospital in Krakow
The third Conference of Rare Cardiovascular Diseases took place at the John Paul II Hospital in Krakow, Poland on the 29th of February 2016. The conference was organized as part of the World Rare Disease Day 2016 annuall...
Stress in adults with congenital heart disease – preliminary results on anxiety, life events, coping and socioeconomic factors (RCD code: IV)
We performed pilot analysis of the anxiety level, frequency of life events and their interactions among adults with congenital heart disease (CHD), and evaluated their coping strategies and socioeconomic functioning. In...
Current views on the use of interferons in the treatment of polycythaemia vera
Interferon alpha is a molecule associated with stimulation of immune system cells, resulting in an anti‐proliferative and immunomodulatory effect. It has been demonstrated that interferon reduces the number of platelets,...